- Capital Cube•6 hours agoGlaxoSmithKline Plc breached its 50 day moving average in a Bearish Manner : GSK-GB : October 25, 2016
Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlaxoSmithKline Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- The Wall Street Journal•7 hours ago
Novartis said net income increased in the third quarter thanks to proceeds from its consumer health joint venture with GlaxoSmithKline, helping to offset declining revenue and heavy investment in its new ...
- American City Business Journals•yesterday
GlaxoSmithKline said Monday it has submitted a biologics license application with the Food and Drug Administration seeking approval for its experimental shingle vaccine. Analysts have projected the new drug candidate, called Shingrix, could develop into a $1 billion a year product — if it receives regulatory approval. Shingles is an acute and painful inflammation of nerve cells that occurs as a result of reactivation of latent chickenpox virus.
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
|Bid||1,641.50 x 175400|
|Ask||1,642.00 x 417900|
|Day's Range||1,637.00 - 1,651.50|
|52wk Range||1,277.25 - 1,745.56|
|1y Target Est||N/A|
|P/E Ratio (ttm)||2,735.83|
|Avg Vol (3m)||7,753,806|
|Dividend & Yield||N/A (N/A)|